Cardiovascular and Metabolic Disease -

Cardiovascular and Metabolic Disease

Scientific Discoveries and New Therapies
Buch | Hardcover
405 Seiten
2015
Royal Society of Chemistry (Verlag)
978-1-78262-046-4 (ISBN)
219,95 inkl. MwSt
This book provides a complete picture of drug discovery for these inter-related conditions by bringing together the latest information and highlighting links between them.
Cardiovascular and metabolic diseases remain the number one cause of death in developed countries and their prevalence is increasing rapidly in developing nations. This book brings together the recent information on these disorders and the links that exist between them in order to provide a complete picture of drug discovery for these conditions.
The main three sections comprehensively discuss obesity, hypertension and cardiovascular disease, and diabetes in turn, following an introduction to the molecular links between them. The final chapter provides perspectives on future directions of the field. Chapters are contributed by leaders in the field from academia and industry and cover biomarkers, risk factors, gene-environment interactions, therapies and the various types of animal models that have been used to study each disease. Case studies describing the implementation of animal models in drug development further enhance the book’s usefulness as a comprehensive guide to this important therapeutic area.
Providing a full picture of the various types of animal models that have been used to study obesity, hypertension, and insulin resistance with recent case studies, this book provides a valuable resource for medicinal chemists and clinicians working in these disease areas.

The Relevance of Biomarkers, Risk Factors and Gene-environment;

Molecular Links between Obesity, Hypertension and Metabolic Dysfunction;

Discovery of Biomarkers of Obesity;

Risk Factors for Obesity;

Gene-environment Interactions in Obesity;

New Drug Design and Therapeutic Development for Weight Reduction: Preclinical Studies and Clinical Trials;

Discovery of Biomarkers of Hypertension and Cardiovascular Disease;

Risk Factors for Hypertension and Cardiovascular Disease;

Gene-environment Interaction and Oxidative Stress in Cardiovascular Disease;

New Drug Design and Therapeutic Development for Hypertension and Cardiovascular Disease;

Discovery of Biomarkers of Diabetes Type 1 and Type 2;

Risk Factors for Diabetes Type 1 and Type 2;

Gene-environment Interactions in Diabetes Type 1 and Type 2;

New Drug Design and Therapeutic Development for Diabetes Type 1 and Type 2;

New Insights and Future Directions

Reihe/Serie Drug Discovery ; Volume 45
Verlagsort Cambridge
Sprache englisch
Maße 156 x 234 mm
Gewicht 727 g
Themenwelt Medizinische Fachgebiete Innere Medizin Kardiologie / Angiologie
Medizin / Pharmazie Medizinische Fachgebiete Pharmakologie / Pharmakotherapie
ISBN-10 1-78262-046-X / 178262046X
ISBN-13 978-1-78262-046-4 / 9781782620464
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
in Fällen, Fragen und Antworten

von Christoph Spes; Volker Klauss; Sibylle Tönjes

Buch | Softcover (2024)
Urban & Fischer in Elsevier (Verlag)
89,00
Diagnostik und interventionelle Therapie | 2 Bände

von Raimund Erbel; Michael Haude; Philipp Kahlert; Björn Plicht …

Buch (2024)
Deutscher Ärzteverlag
349,99